Logo image of ALGBE.PA

GLOBAL BIOENERGIES SA (ALGBE.PA) Stock Price, Quote, News and Overview

EPA:ALGBE - Euronext Paris - Matif - FR0011052257 - Common Stock - Currency: EUR

0.0905  -0.02 (-18.47%)

ALGBE.PA Quote, Performance and Key Statistics

GLOBAL BIOENERGIES SA

EPA:ALGBE (6/18/2025, 7:00:00 PM)

0.0905

-0.02 (-18.47%)

Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustryCommodity Chemicals
Statistics
52 Week High1.95
52 Week Low0.05
Market Cap1.64M
Shares18.17M
Float15.20M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)09-08 2025-09-08
IPO06-09 2011-06-09


ALGBE.PA short term performance overview.The bars show the price performance of ALGBE.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 -40 -60 -80

ALGBE.PA long term performance overview.The bars show the price performance of ALGBE.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ALGBE.PA is 0.0905 EUR. In the past month the price decreased by -91.09%. In the past year, price decreased by -94.46%.

GLOBAL BIOENERGIES SA / ALGBE Daily stock chart

ALGBE.PA Competitors/Peers

The largest stocks on the EU markets in the "Commodity Chemicals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1DOW.MI DOW INC 14.49 18.76B
2OY.DE DOW INC 24.85 17.74B
FPE3.DE FUCHS SE-PREF 25.17 6.10B
FPE.DE FUCHS SE 18.81 4.56B
BEWI.OL BEWI AS N/A 4.00B
SOLV.BR SOLVAC SA-REG 17.56 1.87B
LEN.DE LENZING AG N/A 876.67M
EXPL.PA EXPLOSIFS PROD. CHI 17.48 436.18M
HYDRA.AS HYDRATEC INDUSTRIES NV 11.55 210.60M
ALCRB.PA CARBIOS N/A 122.33M
SERI.MI SERI INDUSTRIAL SPA N/A 119.30M
HOLCO.AS HOLLAND COLOURS NV 15.34 98.04M

About ALGBE.PA

Company Profile

ALGBE logo image Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company is headquartered in Evry, Ile-De-France and currently employs 43 full-time employees. The company went IPO on 2011-06-09. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. The company distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. The company operates through Syngip.

Company Info

GLOBAL BIOENERGIES SA

5, rue Henri Desbrueres

Evry ILE-DE-FRANCE FR

Employees: 43

ALGBE Company Website

ALGBE Investor Relations

Phone: 33164982050

GLOBAL BIOENERGIES SA / ALGBE.PA FAQ

What is the stock price of GLOBAL BIOENERGIES SA today?

The current stock price of ALGBE.PA is 0.0905 EUR. The price decreased by -18.47% in the last trading session.


What is the ticker symbol for GLOBAL BIOENERGIES SA stock?

The exchange symbol of GLOBAL BIOENERGIES SA is ALGBE and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALGBE.PA stock listed?

ALGBE.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for GLOBAL BIOENERGIES SA stock?

9 analysts have analysed ALGBE.PA and the average price target is 3.37 EUR. This implies a price increase of 3619.34% is expected in the next year compared to the current price of 0.0905. Check the GLOBAL BIOENERGIES SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GLOBAL BIOENERGIES SA worth?

GLOBAL BIOENERGIES SA (ALGBE.PA) has a market capitalization of 1.64M EUR. This makes ALGBE.PA a Nano Cap stock.


How many employees does GLOBAL BIOENERGIES SA have?

GLOBAL BIOENERGIES SA (ALGBE.PA) currently has 43 employees.


Is GLOBAL BIOENERGIES SA (ALGBE.PA) expected to grow?

The Revenue of GLOBAL BIOENERGIES SA (ALGBE.PA) is expected to grow by 0.97% in the next year. Check the estimates tab for more information on the ALGBE.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy GLOBAL BIOENERGIES SA (ALGBE.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GLOBAL BIOENERGIES SA (ALGBE.PA) stock pay dividends?

ALGBE.PA does not pay a dividend.


When does GLOBAL BIOENERGIES SA (ALGBE.PA) report earnings?

GLOBAL BIOENERGIES SA (ALGBE.PA) will report earnings on 2025-09-08.


What is the Price/Earnings (PE) ratio of GLOBAL BIOENERGIES SA (ALGBE.PA)?

GLOBAL BIOENERGIES SA (ALGBE.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.32).


ALGBE.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ALGBE.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ALGBE.PA. Both the profitability and financial health of ALGBE.PA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALGBE.PA Financial Highlights

Over the last trailing twelve months ALGBE.PA reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS increased by 33.31% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -60.73%
ROE -346.31%
Debt/Equity 2.78
Chartmill High Growth Momentum
EPS Q2Q%33.52%
Sales Q2Q%-85.13%
EPS 1Y (TTM)33.31%
Revenue 1Y (TTM)-88.9%

ALGBE.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to ALGBE.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 22.81% and a revenue growth 0.97% for ALGBE.PA


Ownership
Inst Owners1.07%
Ins Owners2.68%
Short Float %N/A
Short RatioN/A
Analysts
Analysts84.44
Price Target3.37 (3623.76%)
EPS Next Y22.81%
Revenue Next Year0.97%